FDA Grants Fast-Track Status To New Test For Early-Stage HCC

Reuters (3/4, Miller) reports the FDA granted fast-track status to Roche’s “Elecsys GALAD score, which combines factors including age, gender and biomarker results to more quickly and accurately diagnose early stage hepatocellular carcinoma (HCC).” The co...